CENTOGENE N.V. | Am Strande 7 | 18055 Rostock, Germany

 

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

United States

 

May 17, 2024

 

Re: Notice of disclosure filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria
Human Rights Act of 2012 and Section 13(r) of the Exchange Act

 

Ladies and Gentlemen,

 

Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that Centogene N.V. made disclosure pursuant to those provisions in its Annual Report on Form 20-F for the year ended December 31, 2023, which was filed with the Securities and Exchange Commission on May 15, 2024. The disclosure can be found under the heading “Miscellaneous. Disclosure under Iran Threat Reduction and Syria Human Rights Act of 2012 (ITRA).”

 

Respectfully submitted,  
   
/s/ Kim Stratton  
Kim Stratton  
Chief Executive Officer  
Centogene N.V.  

 

 

CENTOGENE N.V. Management Board Bank Information  
Am Strande 7 Kim Stratton (CEO) Bank: Commerzbank AG  
18055 Rostock, Germany Jose Miguel Coego Rios (CFO) IBAN: DE60130400000108866500  
  Prof. Dr. Peter Bauer (CMGO) BIC: COBADEFFXXX  
Tel.: +49 381 80113-416 Supervisory Board    
Fax: +49 381 80113-401 Peer Schatz (Chairman)    
info@centogene.com      
www.centogene.com      
  Statutory Seat: Amsterdam, registered with the Kamer van Data-Driven,
  Koophandel (Netherlands) under 72822872 Life-Changing Answers

 

 

 


Centogene NV (NASDAQ:CNTG)
過去 株価チャート
から 5 2024 まで 6 2024 Centogene NVのチャートをもっと見るにはこちらをクリック
Centogene NV (NASDAQ:CNTG)
過去 株価チャート
から 6 2023 まで 6 2024 Centogene NVのチャートをもっと見るにはこちらをクリック